Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S, Yuan X, Ma R, Jiang L, Guo J, Zang Y, Shi J, Yang J, Lei P, Liu Z, Zhang Y, Zhu Z. Yang S, et al. Among authors: zang y. Biol Blood Marrow Transplant. 2019 May;25(5):975-980. doi: 10.1016/j.bbmt.2019.01.017. Epub 2019 Jan 15. Biol Blood Marrow Transplant. 2019. PMID: 30658223 Free article.
[Efficacy of combination of ATRA, ATO and anthracyclines induction therapy in patients with acute promyelocytic leukemia].
Ma RJ, Zhu ZM, Yuan XL, Jiang L, Yang SW, Yang J, Guo JM, Zhang L, Lei PC, Wang Z, Zang YZ, Chen YQ, Wang TB, Kong D, Sun K, Zhang Y. Ma RJ, et al. Among authors: zang yz. Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):523-527. doi: 10.3760/cma.j.issn.0253-2727.2017.06.011. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28655097 Free PMC article. Chinese.
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia].
Xu H, Wang P, Ma RJ, Guo JM, Lei PC, Zang YZ, Wang TB, Liu ZW, Yang J, Zhang Y, Zhu ZM. Xu H, et al. Among authors: zang yz. Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):522-525. doi: 10.3760/cma.j.issn.0253-2727.2019.06.014. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31340628 Free PMC article. Chinese. No abstract available.
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy].
Shi J, Sun K, Zhu ZM, Lei PC, Liu ZW, Chen YQ, Guo JM, Zang YZ, Yang J, Zhang Y. Shi J, et al. Among authors: zang yz. Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):693-696. doi: 10.3760/cma.j.issn.0253-2727.2019.08.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31495142 Free PMC article. Chinese. No abstract available.
Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia.
Yang S, Ma R, Yuan X, Jiang L, Shi J, Yang J, Lei P, Zang Y, Chen X, Zhang Y, Liu Z, Guo J, Zhang L, Zhu X, Zhu Z. Yang S, et al. Among authors: zang y. Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e382-e391. doi: 10.1016/j.clml.2019.10.003. Epub 2019 Oct 14. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32336675 Free article.
2,368 results